First Tracks Biotherapeutics, Inc.
TRAX
$44.04
$0.010.02%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Net Income | 21.37% | -6.97% | |||
| Total Depreciation and Amortization | -65.56% | -79.37% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 39.71% | 89.09% | |||
| Change in Net Operating Assets | -153.02% | 240.22% | |||
| Cash from Operations | 17.39% | 27.65% | |||
| Capital Expenditure | 35.90% | 51.43% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -100.00% | 135.18% | |||
| Cash from Investing | -100.07% | 135.62% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | 37.35% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -605.39% | -- | |||
| Cash from Financing | 6.90% | 37.35% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -48.05% | 142.03% | |||